You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies

 

Online download statistics by month:

Online download statistics by month: January 2020 to February 2026

AbstractFullPdf
Jan 202012120
Feb 202030300
Mar 202042421
Apr 202045456
May 2020686816
Jun 202032327
Jul 2020525226
Aug 2020323122
Sep 2020727253
Oct 2020585849
Nov 2020343319
Dec 2020424223
Jan 2021515142
Feb 2021575729
Mar 2021484830
Apr 2021292918
May 2021323227
Jun 2021393929
Jul 2021242423
Aug 2021313119
Sep 2021373717
Oct 2021484847
Nov 2021242418
Dec 2021282917
Jan 2022465019
Feb 2022383934
Mar 2022353617
Apr 2022414222
May 2022424426
Jun 2022323526
Jul 2022343521
Aug 2022394019
Sep 2022313323
Oct 2022262919
Nov 2022353527
Dec 2022272713
Jan 2023464629
Feb 2023222315
Mar 2023393920
Apr 2023131317
May 2023232320
Jun 2023323212
Jul 2023444419
Aug 2023464612
Sep 2023252513
Oct 2023515128
Nov 202318186
Dec 2023313117
Jan 202416168
Feb 2024333316
Mar 2024303125
Apr 2024303026
May 2024343424
Jun 2024242516
Jul 2024333321
Aug 2024262714
Sep 202417179
Oct 2024404040
Nov 2024303016
Dec 2024333322
Jan 2025333333
Feb 202513713735
Mar 2025505023
Apr 2025666635
May 2025414133
Jun 2025404198
Jul 2025110
Feb 2026110
Total249825211506